Clinical trial

Brown Fat Activation Study

NCT02919176

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-09-01

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2016-09-01Date precision: day

Registry last updated2020-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obeseunresolved

Metabolic Syndromeunresolved

Interventions

MirabegronDRUG · verified · RxNorm: mirabegron

PioglitazoneDRUG · verified · RxNorm: pioglitazone

Mirabegron and PioglitazoneDRUG

Sponsors & collaborators

Philip Kernlead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

LexingtonKentucky, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02919176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.